bpc 157 schizophrenia Banned: Key Facts on the Latest FDA Decision BPC 157 Arginate Therapy for
Description
It has been explored for the treatment of neurodegenerative diseases
doi: 10.1080/21553769.2019.1622596
Other contributing factors may include stress, dietary changes, or concurrent medications
Group on behalf of the I 201 S, Beck DE, Sweeney WB, McCarter MD
